Dermatology NewsSecukinumab beat etanercept in 52-week psoriasis quality of life analysisApril 9, 2017PsoriasisPsoriatic Arthritis
Dermatology NewsWhat’s old is new in topical psoriasis therapyApril 5, 2017PsoriasisPsoriatic Arthritis
Dermatology NewsIxekizumab found superior to ustekinumab in psoriasis at 24 weeksMarch 22, 2017PsoriasisPsoriatic Arthritis
Dermatology NewsShingles vaccine deemed effective in people with autoimmune diseaseMarch 21, 2017Psoriatic ArthritisPsoriasisInfectious Diseases
Dermatology NewsClinicians still seek the best uses for apremilastMarch 20, 2017PsoriasisPsoriatic Arthritis
Dermatology NewsAdalimumab for psoriasis: Blocking TNF-alpha had no effect on vascular inflammationMarch 15, 2017PsoriasisPsoriatic Arthritis
Dermatology NewsVIDEO: Stress alleviation strategies boost inflammatory skin treatment regimensMarch 11, 2017PsoriasisAcne
Infection Risk With Biologic Therapy for Psoriasis: Report From the AAD MeetingMarch 7, 2017Psoriasis
Dermatology NewsCIMPASI-1 and -2 show certolizumab pegol benefits patients with severe plaque psoriasisMarch 5, 2017PsoriasisPsoriatic Arthritis
Dermatology NewsPsoriasis and depression may pack a PsA punchMarch 4, 2017PsoriasisPsoriatic Arthritis
Dermatology NewsHumira Pen topped per-person drug spending in 2016February 28, 2017Practice ManagementPsoriasisPsoriatic ArthritisInfectious DiseasesBusiness of Medicine
Dermatology NewsBrodalumab approved for psoriasis with REMS requiredFebruary 16, 2017PsoriasisPsoriatic Arthritis
